Statin use and risk of nonmelanoma skin cancer: a nationwide study in Denmark

被引:12
|
作者
Arnspang, S. [1 ]
Pottegard, A. [1 ,2 ]
Friis, S. [3 ,4 ,5 ]
Clemmensen, O. [6 ]
Andersen, K. E. [7 ,8 ]
Hallas, J. [1 ,2 ]
Gaist, D. [9 ]
机构
[1] Univ Southern Denmark, Inst Publ Hlth, DK-5000 Odense C, Denmark
[2] Odense Univ Hosp, Dept Clin Chem & Pharmacol, DK-5000 Odense C, Denmark
[3] Danish Canc Soc Res Ctr, DK-2100 Copenhagen O, Denmark
[4] Aarhus Univ, Fac Hlth, Inst Clin Med, Aarhus, Denmark
[5] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark
[6] Odense Univ Hosp, Dept Clin Pathol, DK-5000 Odense C, Denmark
[7] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Dept Dermatol,Fac Hlth Sci, DK-5000 Odense C, Denmark
[8] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Allergy Ctr,Fac Hlth Sci, DK-5000 Odense C, Denmark
[9] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Dept Neurol,Fac Hlth Sci, DK-5000 Odense C, Denmark
关键词
skin cancer; nonmelanoma; statins; risk; epidemiology; Denmark; SQUAMOUS-CELL CARCINOMA; METAANALYSIS;
D O I
10.1038/bjc.2014.527
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Evidence is conflicting regarding statin use and risk of basal cell (BCC) and squamous cell skin cancer (SCC). Methods: Using Danish nationwide registries, we identified all patients with incident BCC/SCC during 2005-2009 and matched them to population controls. We computed odds ratios (ORs) for BCC and SCC associated with statin use. Results: We identified 38 484 cases of BCC and 3724 cases of SCC. Statin ever use was associated with ORs of 1.09 (CI: 1.06-1.13) for BCC and 1.01 (CI: 0.91-1.11) for SCC. Conclusions: Statin use was not associated with risk of SCC. Residual confounding plausibly explains the marginally increased risk of BCC.
引用
收藏
页码:153 / 156
页数:4
相关论文
共 50 条
  • [1] Statin use and risk of nonmelanoma skin cancer: a nationwide study in Denmark
    S Arnspang
    A Pottegård
    S Friis
    O Clemmensen
    K E Andersen
    J Hallas
    D Gaist
    [J]. British Journal of Cancer, 2015, 112 : 153 - 156
  • [2] Comment on "Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide caseecontrol study from Denmark''
    van Veelen, Ard
    Nielen, Johannes T. H.
    van Geel, Robin
    Croes, Sander
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E357 - E357
  • [3] Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark
    Pedersen, Sidsel Arnspang
    Gaist, David
    Schmidt, Sigrun Alba Johannesdottir
    Holmich, Lisbet Rosenkrantz
    Friis, Soren
    Pottegard, Anton
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (04) : 673 - +
  • [4] Reply to "Comment on 'Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide caseecontrol study from Denmark'''
    Pedersen, Sidsel Arnspang
    Potteg, Anton
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E359 - E360
  • [5] Mobile Phone Use and the Risk of Skin Cancer: A Nationwide Cohort Study in Denmark
    Poulsen, Aslak Harbo
    Friis, Soren
    Johansen, Christoffer
    Jensen, Allan
    Frei, Patrizia
    Kjaer, Susanne Kruger
    Dalton, Susanne Oksbjerg
    Schuz, Joachim
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (02) : 190 - 197
  • [6] Risk of Nonmelanoma Skin Cancer with Azathioprine Use
    Maddox, Jessica S.
    Soltani, Keyoumars
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (10) : 1425 - 1431
  • [7] Risk of skin cancer in patients with vitiligo in Denmark: A nationwide cohort study
    Jorgensen, Mads Gustaf
    Toyserkani, Navid Mohamadpour
    Egeberg, Alexander
    Sorensen, Jens Ahm
    [J]. JAAD INTERNATIONAL, 2020, 1 (01): : 31 - 38
  • [8] Statin use and risk of skin cancer
    Lin, Brian M.
    Li, Wen-Qing
    Cho, Eunyoung
    Curhan, Gary C.
    Qureshi, Abrar A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (04) : 682 - 693
  • [9] Use of hydrochlorothiazide and risk of melanoma and nonmelanoma skin cancer
    Rouette, Julie
    Yin, Hui
    Pottegard, Anton
    Azoulay, Laurent
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 570 - 570
  • [10] Statin use and risk of contralateral breast cancer: a nationwide cohort study
    Rikke Langballe
    Deirdre Cronin-Fenton
    Christian Dehlendorff
    Maj-Britt Jensen
    Bent Ejlertsen
    Michael Andersson
    Søren Friis
    Lene Mellemkjær
    [J]. British Journal of Cancer, 2018, 119 : 1297 - 1305